Breaking News Instant updates and real-time market news.

PTN

Palatin

$0.33

-0.007 (-2.07%)

, AMAG

AMAG Pharmaceuticals

07:37
03/20/17
03/20
07:37
03/20/17
07:37

Palatin: USPTO isses Notice of Allowance for patent serial number 14/704,223

Palatin Technologies (PTN) announced that the United States Patent and Trademark Office has issued a Notice of Allowance for U.S. Patent Application Serial Number 14/704,223. The allowed claims are for methods of treating female sexual dysfunction and hypoactive sexual desire disorder with bremelanotide, an investigational product designed for on-demand treatment of HSDD in premenopausal women. Once issued, the patent will have a term to November 2033. Stephen Wills, COO and CFO of Palatin, commented, "We are pleased to have received a notice of allowance from the USPTO, which signifies that a patent can be granted from an application. We believe that this patent, with a term out to 2033, further strengthens the intellectual property portfolio for the bremelanotide development program." Palatin previously announced positive Phase 3 results with bremelanotide for treating HSDD in premenopausal women. Palatin has entered into an agreement with AMAG Pharmaceuticals (AMAG) granting AMAG exclusive North American rights to develop and commercialize bremelanotide.

PTN

Palatin

$0.33

-0.007 (-2.07%)

AMAG

AMAG Pharmaceuticals

PTN Palatin
$0.33

-0.007 (-2.07%)

01/10/17
LEER
01/10/17
DOWNGRADE
Target $25
LEER
Market Perform
AMAG Pharmaceuticals downgraded to Market Perform from Outperform at Leerink
Leerink analyst Joseph Schwartz downgraded AMAG Pharmaceuticals (AMAG) to Market Perform from Outperform after the company provided a "disappointing update" related to the Makena auto-injector program. Furthermore, the analyst notes that the licensing agreement with Palatin (PTN) for its hypoactive sexual desire disorder drug Rekynda could drive incremental value but will require "sizable upfront investment" and have to clear regulatory and commercialization hurdles before that takes place. Nonetheless, Schwartz notes that AMAG's preliminary Q4 results and FY17 financial estimates were in-line with his bullish outlook for 2016-2017. He also lowered his price target on AMAG's shares to $25 from $39.
11/02/16
ROTH
11/02/16
NO CHANGE
Target $7
ROTH
Buy
Palatin price target raised to $7 from $4 at Roth Capital
AMAG AMAG Pharmaceuticals

03/15/17
RAJA
03/15/17
NO CHANGE
RAJA
Raymond James says new study highlights risks for AMAG
Raymond James analyst Christopher Raymond says a new study in the American Journal of Obstetrics and Gynecology questions the therapeutic utility of hydroxyprogesterone caproate for preterm birth also highlights a potential safety signal. Hydroxyprogesterone caproate is the active ingredient in AMAG Pharmaceuticals' Makena. The analyst has an Underpeform rating on the shares.
02/03/17
COWN
02/03/17
DOWNGRADE
Target $25
COWN
Market Perform
AMAG Pharmaceuticals downgraded to Market Perform from Outperform at Cowen
Cowen analyst Ken Cacciatore downgraded AMAG Pharmaceuticals to Market Perform from Outperform on the belief that the franchise extension strategy for Makena will unfortunately fail. The analyst also questions the business decisions made after acquiring Makena, such as buying CBR, which could prove to be value destroying. Cacciatore lowered his price target to $25 from $35 on AMAG Pharmaceuticals shares.
01/31/17
JPMS
01/31/17
NO CHANGE
Target $24
JPMS
Neutral
AMAG Pharmaceuticals price target lowered to $24 from $33 at JPMorgan
JPMorgan analyst Jessica Fye lowered her price target for AMAG Pharmaceuticals to $24 following updates at her firm's healthcare conference, including the shift in Makena strategy, Rekynda in-licensing and 2017 guidance. The analyst keeps a Neutral rating on the shares.
01/10/17
NEED
01/10/17
DOWNGRADE
NEED
Hold
AMAG Pharmaceuticals downgraded to Hold from Buy at Needham

TODAY'S FREE FLY STORIES

SXI

Standex

$88.80

-0.05 (-0.06%)

10:40
05/23/17
05/23
10:40
05/23/17
10:40
Conference/Events
Standex management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBPX

Continental Building

$24.15

0.05 (0.21%)

10:39
05/23/17
05/23
10:39
05/23/17
10:39
Conference/Events
Continental Building management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MXIM

Maxim Integrated

$46.69

-0.16 (-0.34%)

10:38
05/23/17
05/23
10:38
05/23/17
10:38
Hot Stocks
Maxim Integrated anticipates strong cash flow growth »

All strategies are geared…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

10:35
05/23/17
05/23
10:35
05/23/17
10:35
General news
The 11.4% April new home sales plunge »

The 11.4% April new home…

TARO

Taro Pharmaceutical

$108.86

-3.465 (-3.08%)

10:32
05/23/17
05/23
10:32
05/23/17
10:32
Downgrade
Taro Pharmaceutical rating change  »

Taro Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MXIM

Maxim Integrated

$46.69

-0.16 (-0.34%)

10:30
05/23/17
05/23
10:30
05/23/17
10:30
Hot Stocks
Maxim says has 'great' products for power management in industrial business »

The company sees factory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

EWS

iShares MSCI Singapore Index

$23.77

-0.06 (-0.25%)

10:30
05/23/17
05/23
10:30
05/23/17
10:30
Options
Opening interest in iShares MSCI Singapore ETF options »

Opening interest in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLND

Talend

$31.85

-0.16 (-0.50%)

10:28
05/23/17
05/23
10:28
05/23/17
10:28
Conference/Events
Talend management to meet with William Blair »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 30

    May

  • 13

    Jun

WYN

Wyndham

$96.72

0.73 (0.76%)

10:28
05/23/17
05/23
10:28
05/23/17
10:28
Conference/Events
Wyndham management to meet with MKM Partners »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

SOHU

Sohu.com

$49.22

3.09 (6.70%)

10:27
05/23/17
05/23
10:27
05/23/17
10:27
Downgrade
Sohu.com rating change  »

Sohu.com downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHP

BHP Billiton

$36.45

-0.44 (-1.19%)

, BCS

Barclays

$11.10

-0.04 (-0.36%)

10:26
05/23/17
05/23
10:26
05/23/17
10:26
Periodicals
BHP hires Barclays to divest U.S. shale gas assets, Reuters reports »

BHP (BHP) has hired…

BHP

BHP Billiton

$36.45

-0.44 (-1.19%)

BCS

Barclays

$11.10

-0.04 (-0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

TWOU

2U

$42.99

1 (2.38%)

10:26
05/23/17
05/23
10:26
05/23/17
10:26
Conference/Events
2U management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

STL

Sterling Bancorp

$21.75

-0.1 (-0.46%)

10:25
05/23/17
05/23
10:25
05/23/17
10:25
Conference/Events
Sterling Bancorp management to meet with Sandler O'Neill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 25

    May

LULU

lululemon

$49.51

0.22 (0.45%)

10:25
05/23/17
05/23
10:25
05/23/17
10:25
Hot Stocks
lululemon falls following website outages »

Shares of lululemon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Jun

SAP

SAP

$106.14

0.4 (0.38%)

10:24
05/23/17
05/23
10:24
05/23/17
10:24
Conference/Events
SAP management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 31

    May

MXIM

Maxim Integrated

$46.69

-0.16 (-0.34%)

10:24
05/23/17
05/23
10:24
05/23/17
10:24
Hot Stocks
Breaking Hot Stocks news story on Maxim Integrated »

Maxim Integrated sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

JNJ

Johnson & Johnson

$128.09

0.83 (0.65%)

10:23
05/23/17
05/23
10:23
05/23/17
10:23
Hot Stocks
Breaking Hot Stocks news story on Johnson & Johnson »

J&J CFO says creating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

  • 06

    Jun

ONB

Old National Bancorp

$16.10

-0.05 (-0.31%)

10:22
05/23/17
05/23
10:22
05/23/17
10:22
Conference/Events
Old National Bancorp management to meet with Sandler O'Neill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 25

    May

  • 18

    Sep

MXIM

Maxim Integrated

$46.69

-0.16 (-0.34%)

, NVDA

Nvidia

$138.90

2.9 (2.13%)

10:22
05/23/17
05/23
10:22
05/23/17
10:22
Hot Stocks
Maxim says partnership with Nvidia 'works well,' no conflicts »

Also working with Nvidia…

MXIM

Maxim Integrated

$46.69

-0.16 (-0.34%)

NVDA

Nvidia

$138.90

2.9 (2.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

  • 01

    Jun

  • 09

    Jun

JNJ

Johnson & Johnson

$128.09

0.83 (0.65%)

10:21
05/23/17
05/23
10:21
05/23/17
10:21
Hot Stocks
Johnson & Johnson says wants to generate value for shareholders in any M&A deals »

Says looking at strategic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

  • 06

    Jun

OFC

Corporate Office Properties

$33.66

0.08 (0.24%)

10:21
05/23/17
05/23
10:21
05/23/17
10:21
Conference/Events
Corporate Office Properties management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

ALXN

Alexion

$115.42

1.58 (1.39%)

10:21
05/23/17
05/23
10:21
05/23/17
10:21
Downgrade
Alexion rating change  »

Alexion downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

CLDR

Cloudera

$21.32

0.41 (1.96%)

, EEX

Emerald Expositions Events

$21.93

-0.075 (-0.34%)

10:21
05/23/17
05/23
10:21
05/23/17
10:21
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

CLDR

Cloudera

$21.32

0.41 (1.96%)

EEX

Emerald Expositions Events

$21.93

-0.075 (-0.34%)

ZYME

Zymeworks

$13.00

-0.06 (-0.46%)

CVNA

Carvana

$11.20

0.1165 (1.05%)

JBHT

J.B. Hunt

$84.25

0.11 (0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

  • 23

    May

  • 25

    May

  • 31

    May

  • 02

    Jun

  • 08

    Jun

AZO

AutoZone

$603.74

-55.75 (-8.45%)

, HP

Helmerich & Payne

$56.79

-3.09 (-5.16%)

10:21
05/23/17
05/23
10:21
05/23/17
10:21
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

AZO

AutoZone

$603.74

-55.75 (-8.45%)

HP

Helmerich & Payne

$56.79

-3.09 (-5.16%)

FRSH

Papa Murphy's

$5.04

0.03 (0.60%)

COLM

Columbia Sportswear

$53.17

0.51 (0.97%)

XLNX

Xilinx

$67.52

0.85 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

  • 24

    May

  • 01

    Jun

  • 13

    Jun

MCK

McKesson

$158.56

3.14 (2.02%)

, AEGN

Aegion

$19.48

0.01 (0.05%)

10:21
05/23/17
05/23
10:21
05/23/17
10:21
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

MCK

McKesson

$158.56

3.14 (2.02%)

AEGN

Aegion

$19.48

0.01 (0.05%)

WING

Wingstop

$29.65

-0.53 (-1.76%)

PRXL

Parexel

$79.31

0.16 (0.20%)

ONDK

On Deck Capital

$3.77

0.14 (3.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 26

    May

  • 06

    Jun

  • 20

    Jun

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.